Changes in exhaled nitric oxide after ingestion of L-arginine in children

a pilot study

Ibrahim Abuzayan, Stephen W Turner

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Rationale: Exhaled nitric oxide (FENO) may be a useful biomarker for asthma and is derived from enzymatic activity on the amino acid L-arginine. The aim of the present pilot study was to study the effect of L-arginine ingestion on FENO and alsoNOproduction in the proximal and distal airways. Methods: Asthmatic and control children were enrolled and phenotyped by skin prick reactivity and spirometry. FENO was measured before and after ingestion of 0.2 g/kg L arginine. Proximal and distal NO production (J’awNO and CANO) were derived using the method of Tsoukias. Results: Twenty children were recruited, 11 steroid-treated asthmatics, 1 steroid-nai¨ve asthmatic, and 8 healthy controls. The median baseline FENO before L-arginine administrationwas 31 ppb (interquartile range, IQR, 15, 61). At baseline, the median J’awNO was 1000 nl/sec (IQR 650, 2880) and the median CANO was 2.3 ppb (IQR 1.8, 4.5). FENO rose by an average of 5.5 ppb [95% CI 3.5, 7.5] (P<0.001) 60 min after ingestion of L-arginine and 1.5 ppb [95% CI 0.9, 4.0] (P¼0.188) after 120 min. One hour after L-arginine ingestion, J’awNO did not change but CANO rose by an average of 2.6 ppb [95% CI 0.5, 4.7], P¼0.020. Conclusion: The rise in FENO
after dietary exposure to L-arginine is modest, transient, and of little or no clinical significance.
Original languageEnglish
Pages (from-to)236-240
Number of pages5
JournalPediatric Pulmonology
Volume45
Issue number3
Early online date3 Feb 2010
DOIs
Publication statusPublished - Mar 2010

Fingerprint

Arginine
Nitric Oxide
Eating
Steroids
Spirometry
Asthma
Biomarkers
Amino Acids
Skin

Keywords

  • asthma
  • child
  • L-arginine
  • nitric oxide

Cite this

Changes in exhaled nitric oxide after ingestion of L-arginine in children : a pilot study. / Abuzayan, Ibrahim; Turner, Stephen W.

In: Pediatric Pulmonology, Vol. 45, No. 3, 03.2010, p. 236-240.

Research output: Contribution to journalArticle

@article{83e947af6c31451881d0f464b5c48569,
title = "Changes in exhaled nitric oxide after ingestion of L-arginine in children: a pilot study",
abstract = "Rationale: Exhaled nitric oxide (FENO) may be a useful biomarker for asthma and is derived from enzymatic activity on the amino acid L-arginine. The aim of the present pilot study was to study the effect of L-arginine ingestion on FENO and alsoNOproduction in the proximal and distal airways. Methods: Asthmatic and control children were enrolled and phenotyped by skin prick reactivity and spirometry. FENO was measured before and after ingestion of 0.2 g/kg L arginine. Proximal and distal NO production (J’awNO and CANO) were derived using the method of Tsoukias. Results: Twenty children were recruited, 11 steroid-treated asthmatics, 1 steroid-nai¨ve asthmatic, and 8 healthy controls. The median baseline FENO before L-arginine administrationwas 31 ppb (interquartile range, IQR, 15, 61). At baseline, the median J’awNO was 1000 nl/sec (IQR 650, 2880) and the median CANO was 2.3 ppb (IQR 1.8, 4.5). FENO rose by an average of 5.5 ppb [95{\%} CI 3.5, 7.5] (P<0.001) 60 min after ingestion of L-arginine and 1.5 ppb [95{\%} CI 0.9, 4.0] (P¼0.188) after 120 min. One hour after L-arginine ingestion, J’awNO did not change but CANO rose by an average of 2.6 ppb [95{\%} CI 0.5, 4.7], P¼0.020. Conclusion: The rise in FENO after dietary exposure to L-arginine is modest, transient, and of little or no clinical significance.",
keywords = "asthma, child, L-arginine, nitric oxide",
author = "Ibrahim Abuzayan and Turner, {Stephen W}",
year = "2010",
month = "3",
doi = "10.1002/ppul.21110",
language = "English",
volume = "45",
pages = "236--240",
journal = "Pediatric Pulmonology",
issn = "8755-6863",
publisher = "John Wiley & Sons, Ltd",
number = "3",

}

TY - JOUR

T1 - Changes in exhaled nitric oxide after ingestion of L-arginine in children

T2 - a pilot study

AU - Abuzayan, Ibrahim

AU - Turner, Stephen W

PY - 2010/3

Y1 - 2010/3

N2 - Rationale: Exhaled nitric oxide (FENO) may be a useful biomarker for asthma and is derived from enzymatic activity on the amino acid L-arginine. The aim of the present pilot study was to study the effect of L-arginine ingestion on FENO and alsoNOproduction in the proximal and distal airways. Methods: Asthmatic and control children were enrolled and phenotyped by skin prick reactivity and spirometry. FENO was measured before and after ingestion of 0.2 g/kg L arginine. Proximal and distal NO production (J’awNO and CANO) were derived using the method of Tsoukias. Results: Twenty children were recruited, 11 steroid-treated asthmatics, 1 steroid-nai¨ve asthmatic, and 8 healthy controls. The median baseline FENO before L-arginine administrationwas 31 ppb (interquartile range, IQR, 15, 61). At baseline, the median J’awNO was 1000 nl/sec (IQR 650, 2880) and the median CANO was 2.3 ppb (IQR 1.8, 4.5). FENO rose by an average of 5.5 ppb [95% CI 3.5, 7.5] (P<0.001) 60 min after ingestion of L-arginine and 1.5 ppb [95% CI 0.9, 4.0] (P¼0.188) after 120 min. One hour after L-arginine ingestion, J’awNO did not change but CANO rose by an average of 2.6 ppb [95% CI 0.5, 4.7], P¼0.020. Conclusion: The rise in FENO after dietary exposure to L-arginine is modest, transient, and of little or no clinical significance.

AB - Rationale: Exhaled nitric oxide (FENO) may be a useful biomarker for asthma and is derived from enzymatic activity on the amino acid L-arginine. The aim of the present pilot study was to study the effect of L-arginine ingestion on FENO and alsoNOproduction in the proximal and distal airways. Methods: Asthmatic and control children were enrolled and phenotyped by skin prick reactivity and spirometry. FENO was measured before and after ingestion of 0.2 g/kg L arginine. Proximal and distal NO production (J’awNO and CANO) were derived using the method of Tsoukias. Results: Twenty children were recruited, 11 steroid-treated asthmatics, 1 steroid-nai¨ve asthmatic, and 8 healthy controls. The median baseline FENO before L-arginine administrationwas 31 ppb (interquartile range, IQR, 15, 61). At baseline, the median J’awNO was 1000 nl/sec (IQR 650, 2880) and the median CANO was 2.3 ppb (IQR 1.8, 4.5). FENO rose by an average of 5.5 ppb [95% CI 3.5, 7.5] (P<0.001) 60 min after ingestion of L-arginine and 1.5 ppb [95% CI 0.9, 4.0] (P¼0.188) after 120 min. One hour after L-arginine ingestion, J’awNO did not change but CANO rose by an average of 2.6 ppb [95% CI 0.5, 4.7], P¼0.020. Conclusion: The rise in FENO after dietary exposure to L-arginine is modest, transient, and of little or no clinical significance.

KW - asthma

KW - child

KW - L-arginine

KW - nitric oxide

U2 - 10.1002/ppul.21110

DO - 10.1002/ppul.21110

M3 - Article

VL - 45

SP - 236

EP - 240

JO - Pediatric Pulmonology

JF - Pediatric Pulmonology

SN - 8755-6863

IS - 3

ER -